JP2017512066A5 - - Google Patents

Download PDF

Info

Publication number
JP2017512066A5
JP2017512066A5 JP2016568144A JP2016568144A JP2017512066A5 JP 2017512066 A5 JP2017512066 A5 JP 2017512066A5 JP 2016568144 A JP2016568144 A JP 2016568144A JP 2016568144 A JP2016568144 A JP 2016568144A JP 2017512066 A5 JP2017512066 A5 JP 2017512066A5
Authority
JP
Japan
Prior art keywords
polypeptide
nucleic acid
use according
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016568144A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017512066A (ja
Filing date
Publication date
Priority claimed from GBGB1402352.7A external-priority patent/GB201402352D0/en
Application filed filed Critical
Publication of JP2017512066A publication Critical patent/JP2017512066A/ja
Publication of JP2017512066A5 publication Critical patent/JP2017512066A5/ja
Pending legal-status Critical Current

Links

JP2016568144A 2014-02-11 2015-02-11 フィラリア線虫ワクチン、ポリペプチド、および核酸 Pending JP2017512066A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1402352.7A GB201402352D0 (en) 2014-02-11 2014-02-11 Vaccines, polypeptides, and nucleic acids
GB1402352.7 2014-02-11
PCT/GB2015/050380 WO2015121646A1 (en) 2014-02-11 2015-02-11 Filarial nematode vaccines, polypeptides, and nucleic acids

Publications (2)

Publication Number Publication Date
JP2017512066A JP2017512066A (ja) 2017-05-18
JP2017512066A5 true JP2017512066A5 (enExample) 2018-03-15

Family

ID=50390804

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016568144A Pending JP2017512066A (ja) 2014-02-11 2015-02-11 フィラリア線虫ワクチン、ポリペプチド、および核酸

Country Status (7)

Country Link
US (2) US9994624B2 (enExample)
EP (2) EP3693008A1 (enExample)
JP (1) JP2017512066A (enExample)
AU (2) AU2015216783A1 (enExample)
CA (1) CA2939236C (enExample)
GB (1) GB201402352D0 (enExample)
WO (1) WO2015121646A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201402352D0 (en) 2014-02-11 2014-03-26 Univ Liverpool Vaccines, polypeptides, and nucleic acids
WO2017173369A1 (en) 2016-04-01 2017-10-05 New York Blood Center, Inc. Biomakers and immunogenic compositions for filarial parasites
WO2017176950A2 (en) 2016-04-07 2017-10-12 Merial, Inc. Heartworm vaccine, methods and uses thereof
MX2024004078A (es) * 2021-10-04 2024-04-18 Agresearch Ltd Vacuna contra nematodos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265198B1 (en) 1994-05-26 2001-07-24 Heska Corporation Parasite astacin metalloendopeptidase proteins
MY160430A (en) 2008-12-12 2017-03-15 Univ Sains Malaysia Recombinant antigen for detection of toxocariasis
US20130236490A1 (en) 2010-11-15 2013-09-12 The Board Of Trustees Of The University Of Illinois Multivalent Vaccine for Filariasis
GB201402352D0 (en) 2014-02-11 2014-03-26 Univ Liverpool Vaccines, polypeptides, and nucleic acids

Similar Documents

Publication Publication Date Title
RU2017119647A (ru) Способ лечения болезней глаз
EA201490610A1 (ru) Соединения и способы усиления врожденных иммунных ответов
MX383614B (es) Proteinas de union triespecificas y metodos de uso.
EA201891876A1 (ru) Тетрациклические пиридоновые соединения в качестве противовирусных средств
MX2018008557A (es) Anticuerpos peptidicos beta amiloide anti-n3pglu y usos de los mismos.
EA201800367A1 (ru) Способы лечения болезни хантингтона
AR106753A1 (es) Proteínas de unión a ctla4p
MX2015013065A (es) Proteinas f de rsv de prefusion y su uso.
PE20170673A1 (es) Terapia de combinacion para tratar una paramixovirus
JP2017512066A5 (enExample)
PE20150356A1 (es) Composiciones de vacuna para la prevencion contra la infeccion por el virus del dengue
BR112015021414A2 (pt) vírus da doença newcastle e seus usos
EA201791903A1 (ru) β-D-2'-ДЕЗОКСИ-2'-α-ФТОР-2'-β-C-ЗАМЕЩЕННЫЕ-2-МОДИФИЦИРОВАННЫЕ-N6-ЗАМЕЩЕННЫЕ ПУРИНОВЫЕ НУКЛЕОТИДЫ ДЛЯ ЛЕЧЕНИЯ ВЫЗВАННЫХ HCV ЗАБОЛЕВАНИЙ
HRP20210577T1 (hr) Sastavi i načini liječenja i sprječavanje upale
BR112015024552A2 (pt) compostos de fórmula (a), composição farmacêutica, métodos para a preparação do composto e métodos de tratamento ou prevenção de infecções
EP3500278C0 (en) COMPOSITIONS FOR THE TREATMENT OF CONDITIONS USING A SELF-COMPLEMENTARY RECOMBINANT ADENO-ASSOCIATED VIRUS
JP2017526689A5 (enExample)
JO3281B1 (ar) مركبات بينزوفوران لمعالجة عدوى فيروس إلتهاب الكبد الوبائي
EA202091769A1 (ru) Вакцины против вируса гриппа и пути их применения
WO2016061504A3 (en) Recombinant antibodies that recongnize the c-terminal domains of ebola virus nucleoprotein
EA201500643A1 (ru) Парвовирус свиней 5а, способы применения и вакцина
CN109790123A (zh) 新型衣壳蛋白装配抑制剂
EA201992626A1 (ru) Способы и композиции для лечения аллергических заболеваний глаз
EA201500837A1 (ru) Парвовирус свиней 5в, способы применения и вакцина
EA202090164A1 (ru) Изотретиноиновые перорально-слизистые композиции и способы их применения